Literature DB >> 22374887

Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis.

Srikanth Santhanam1, Subapriya Rajamanickam, Anjan Motamarry, Balakrishnan S Ramakrishna, Jayakumar G Amirtharaj, Anup Ramachandran, Anna Pulimood, Aparna Venkatraman.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is characterized by an energy deficiency state of the colonic epithelium. This study evaluated mitochondrial electron transport chain (ETC) complex activity in normal and disease mucosa in patients with UC. Alterations in ETC complexes were also investigated in experimental colitis in mice.
METHODS: Biopsies were obtained from macroscopically normal and diseased colonic mucosa of 43 patients with UC and 35 controls undergoing screening colonoscopy and ETC complex activity was assayed biochemically. ETC complex activities were also assayed in colonic epithelial cells isolated from Swiss albino mice with dextran sodium sulfate (DSS)-induced colitis at various stages of induction of colitis. Mucosal nitrite levels and protein carbonyl content were determined.
RESULTS: The activity of Complex II was significantly decreased in colonic biopsies from UC patients compared with controls, while activities of other mitochondrial complex were normal. Complex II activity was equally decreased in diseased and normal mucosa in UC; the degree of reduction did not correlate with clinical, endoscopic, or histological grading of disease activity. In DSS-fed mice, a reduction in activity of Complex IV and Complex II was observed. Activity of other complex was not affected. Administration of aminoguanidine, an inducible nitric oxide synthase (iNOS) inhibitor, attenuated all parameters of colitis as well as the reductions in Complex IV and Complex II activity.
CONCLUSIONS: Reduction in Complex II activity appears to be a specific change in UC, present in quiescent and active disease. Mitochondrial complex dysfunction occurs in DSS colitis in mice and appears to be mediated by nitric oxide.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374887     DOI: 10.1002/ibd.22926

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  34 in total

Review 1.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 2.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

Review 3.  Stat3: friend or foe in colitis and colitis-associated cancer?

Authors:  Jie Han; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 4.  Oxygen metabolism and barrier regulation in the intestinal mucosa.

Authors:  Louise E Glover; J Scott Lee; Sean P Colgan
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

5.  Activation of NLRX1 by NX-13 Alleviates Inflammatory Bowel Disease through Immunometabolic Mechanisms in CD4+ T Cells.

Authors:  Andrew Leber; Raquel Hontecillas; Victoria Zoccoli-Rodriguez; Catherine Bienert; Jyoti Chauhan; Josep Bassaganya-Riera
Journal:  J Immunol       Date:  2019-11-06       Impact factor: 5.422

6.  Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation.

Authors:  Garret Vincent; Elizabeth A Novak; Vei Shaun Siow; Kellie E Cunningham; Brian D Griffith; Thomas E Comerford; Heather L Mentrup; Donna B Stolz; Patricia Loughran; Sarangarajan Ranganathan; Kevin P Mollen
Journal:  Antioxid Redox Signal       Date:  2020-03-31       Impact factor: 8.401

7.  Flavaglines Ameliorate Experimental Colitis and Protect Against Intestinal Epithelial Cell Apoptosis and Mitochondrial Dysfunction.

Authors:  Jie Han; Qian Zhao; Christine Basmadjian; Laurent Désaubry; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

8.  Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis.

Authors:  Kellie E Cunningham; Garret Vincent; Chhinder P Sodhi; Elizabeth A Novak; Sarangarajan Ranganathan; Charlotte E Egan; Donna Beer Stolz; Matthew B Rogers; Brian Firek; Michael J Morowitz; George K Gittes; Brian S Zuckerbraun; David J Hackam; Kevin P Mollen
Journal:  J Biol Chem       Date:  2016-03-11       Impact factor: 5.157

9.  Mitochondria and tumor progression in ulcerative colitis.

Authors:  Cigdem Himmetoglu Ussakli; Anoosheh Ebaee; Jennifer Binkley; Teresa A Brentnall; Mary J Emond; Peter S Rabinovitch; Rosa Ana Risques
Journal:  J Natl Cancer Inst       Date:  2013-07-12       Impact factor: 13.506

10.  Prohibitin 1 modulates mitochondrial function of Stat3.

Authors:  Jie Han; Chunhua Yu; Rhonda F Souza; Arianne L Theiss
Journal:  Cell Signal       Date:  2014-06-26       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.